Show simple item record

dc.contributor.authorKanchi, M.
dc.contributor.authorShanmugam, M.
dc.contributor.authorRane, G.
dc.contributor.authorSethi, G.
dc.contributor.authorKumar, Alan Prem
dc.identifier.citationKanchi, M. and Shanmugam, M. and Rane, G. and Sethi, G. and Kumar, A.P. 2017. Tocotrienols: the unsaturated sidekick shifting new paradigms in vitamin E therapeutics. Drug Discovery Today. 22 (12): pp. 1765-1781.

© 2017 Elsevier Ltd Vitamin E family members: tocotrienols and tocopherols are widely known for their health benefits. Decades of research on tocotrienols have shown they have diverse biological activities such as antioxidant, anti-inflammatory, anticancer, neuroprotective and skin protection benefits, as well as improved cognition, bone health, longevity and reduction of cholesterol levels in plasma. Tocotrienols also modulate several intracellular molecular targets and, most importantly, have been shown to improve lipid profiles, reduce total cholesterol and reduce the volume of white matter lesions in human clinical trials. This review provides a comprehensive update on the little-known therapeutic potentials of tocotrienols, which tocopherols lack in a variety of inflammation-driven diseases. Vitamin E is a lipid-soluble, radical buster existing in two different isoforms: tocotrienols and tocopherols, and has been used continuously because of its many biological activities, which are pharmacologically capable of tackling a wide array of diseases, thus improving health issues occurring every day.

dc.publisherElsevier Science Ltd
dc.titleTocotrienols: the unsaturated sidekick shifting new paradigms in vitamin E therapeutics
dc.typeJournal Article
dcterms.source.titleDrug Discovery Today
curtin.departmentCurtin Medical School
curtin.accessStatusFulltext not available

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record